Literature DB >> 28187526

Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis.

Hailong Cao1,2, Mengque Xu1,3, Wenxiao Dong1, Baoru Deng1, Sinan Wang1, Yujie Zhang4, Shan Wang1, Shenhui Luo1, Weiqiang Wang1, Yanrong Qi5, Jianxin Gao5, Xiaocang Cao1, Fang Yan1,2, Bangmao Wang1.   

Abstract

The gut microbiota plays an important role in maintaining intestinal homeostasis. Dysbiosis is associated with intestinal tumorigenesis. Deoxycholic acid (DCA), a secondary bile acid increased by a western diet, correlates with intestinal carcinogenesis. However, evidence relating bile acids, intestinal microbiota and tumorigenesis are limited. In our study, we investigated the effect of DCA on induction of intestinal dysbiosis and its roles in intestinal carcinogenesis. Alteration of the composition of the intestinal microbiota was induced in DCA-treated APCmin/+ mice, which was accompanied by impaired intestinal barrier, gut low grade inflammation and tumor progression. The transfer of fecal microbiota from DCA-treated mice to another group of Apcmin/+ mice increased tumor multiplicity, induced inflammation and recruited M2 phenotype tumor-associated macrophages. Importantly, the fecal microbiota transplantation activated the tumor-associated Wnt/β-catenin signaling pathway. Moreover, microbiota depletion by a cocktail of antibiotics was sufficient to block DCA-induced intestinal carcinogenesis, further suggesting the role of dysbiosis in tumor development. Our study demonstrated that alteration of the microbial community induced by DCA promoted intestinal carcinogenesis.
© 2017 UICC.

Entities:  

Keywords:  Apcmin/+ mice; deoxycholic acid; intestinal carcinogenesis; intestinal microbiota; tumor-associated macrophages

Mesh:

Substances:

Year:  2017        PMID: 28187526     DOI: 10.1002/ijc.30643

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  68 in total

1.  A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer.

Authors:  Soeren Ocvirk; Annette S Wilson; Joram M Posma; Jia V Li; Kathryn R Koller; Gretchen M Day; Christie A Flanagan; Jill Evon Otto; Pam E Sacco; Frank D Sacco; Flora R Sapp; Amy S Wilson; Keith Newton; Faye Brouard; James P DeLany; Marissa Behnning; Corynn N Appolonia; Devavrata Soni; Faheem Bhatti; Barbara Methé; Adam Fitch; Alison Morris; H Rex Gaskins; James Kinross; Jeremy K Nicholson; Timothy K Thomas; Stephen J D O'Keefe
Journal:  Am J Clin Nutr       Date:  2020-02-01       Impact factor: 7.045

Review 2.  Novel insights into microbiome in colitis and colorectal cancer.

Authors:  Ye Yang; Christian Jobin
Journal:  Curr Opin Gastroenterol       Date:  2017-11       Impact factor: 3.287

Review 3.  Conceptualizing the Vertebrate Sterolbiome.

Authors:  Jason M Ridlon
Journal:  Appl Environ Microbiol       Date:  2020-08-03       Impact factor: 4.792

Review 4.  Interplay of Liver Disease and Gut Microbiota in the Development of Colorectal Neoplasia.

Authors:  Michael W Gleeson
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

5.  Dietary inflammatory potential in relation to the gut microbiome: results from a cross-sectional study.

Authors:  Jiali Zheng; Kristi L Hoffman; Jiun-Sheng Chen; Nitin Shivappa; Akhil Sood; Gladys J Browman; Danika D Dirba; Samir Hanash; Peng Wei; James R Hebert; Joseph F Petrosino; Susan M Schembre; Carrie R Daniel
Journal:  Br J Nutr       Date:  2020-06-01       Impact factor: 3.718

Review 6.  Fiber, Fat, and Colorectal Cancer: New Insight into Modifiable Dietary Risk Factors.

Authors:  Soeren Ocvirk; Annette S Wilson; Corynn N Appolonia; Timothy K Thomas; Stephen J D O'Keefe
Journal:  Curr Gastroenterol Rep       Date:  2019-12-02

Review 7.  Metformin, Microbiome and Protection Against Colorectal Cancer.

Authors:  Georgina R Jones; Mark P Molloy
Journal:  Dig Dis Sci       Date:  2020-06-12       Impact factor: 3.199

Review 8.  Nutraceuticals in colorectal cancer: A mechanistic approach.

Authors:  Marco Rossi; S E Y E D Sina Mirbagheri; Ali Keshavarzian; Faraz Bishehsari
Journal:  Eur J Pharmacol       Date:  2018-06-20       Impact factor: 4.432

9.  Modulation of intestinal microbiota by glycyrrhizic acid prevents high-fat diet-enhanced pre-metastatic niche formation and metastasis.

Authors:  Miao Qiu; Keqing Huang; Yanzhuo Liu; Yuqing Yang; Honglin Tang; Xiaoxiao Liu; Chenlong Wang; Honglei Chen; Yu Xiong; Jing Zhang; Jing Yang
Journal:  Mucosal Immunol       Date:  2019-02-12       Impact factor: 7.313

10.  Influence of Bile Acids on Colorectal Cancer Risk: Potential Mechanisms Mediated by Diet - Gut Microbiota Interactions.

Authors:  Sören Ocvirk; Stephen Jd O'Keefe
Journal:  Curr Nutr Rep       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.